Episode
Matthew Rabinowitz: Engineering a New Era of Diagnosis
- Podcast
- Behind the Breakthroughs
- Published
- May 6, 2026
- Duration seconds
- 4038
- Processing state
not_requested- Canonical source
- https://shows.acast.com/behind-the-breakthroughs-by-inside-precision-medicine/episodes/matthew-rabinowitz-engineering-a-new-era-of-diagnosis
Actions
POST https://stenobird.com/v1/public/podcasts/behind-the-breakthroughs-7055075/episodes/matthew-rabinowitz-engineering-a-new-era-of-diagnosis/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/behind-the-breakthroughs-7055075/matthew-rabinowitz-engineering-a-new-era-of-diagnosis.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Matthew Rabinowitz, PhD, moved from engineering to medicine after his Human Genome Project work, motivated by both scientific insight and personal loss that exposed the limits of existing genetic diagnostics. He founded Natera and later Myome, building genomic and AI-driven tools to improve disease detection, risk assessment, and prevention. In the episode, he highlights challenges. such as regulatory barriers, fragmented data, and translating genetics into clinical decisions, while aiming to develop predictive blood tests that enable proactive care. Produced and hosted by Jonathan D. Grinstein, PhD Audio mixed and mastered by Erick Ziegler Brought to you by Inside Precision Medicine (SAGE Publishing) Hosted on Acast. See acast.com/privacy for more information.